- Home
- IMAB vs LSBK Comparison
IMAB vs LSBK Comparison
Compare IMAB & LSBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- LSBK
- Stock Information
- Founded
- IMAB 2014
- LSBK 1891
- Country
- IMAB United States
- LSBK United States
- Employees
- IMAB N/A
- LSBK N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- LSBK Savings Institutions
- Sector
- IMAB Health Care
- LSBK Finance
- Exchange
- IMAB Nasdaq
- LSBK Nasdaq
- Market Cap
- IMAB 384.6M
- LSBK 90.0M
- IPO Year
- IMAB 2020
- LSBK 2006
- Fundamental
- Price
- IMAB $3.69
- LSBK $13.05
- Analyst Decision
- IMAB Strong Buy
- LSBK
- Analyst Count
- IMAB 5
- LSBK 0
- Target Price
- IMAB $6.80
- LSBK N/A
- AVG Volume (30 Days)
- IMAB 1.7M
- LSBK 25.9K
- Earning Date
- IMAB 11-02-2025
- LSBK 10-22-2025
- Dividend Yield
- IMAB N/A
- LSBK 2.76%
- EPS Growth
- IMAB N/A
- LSBK 39.59
- EPS
- IMAB N/A
- LSBK 1.05
- Revenue
- IMAB N/A
- LSBK $26,488,000.00
- Revenue This Year
- IMAB N/A
- LSBK N/A
- Revenue Next Year
- IMAB N/A
- LSBK N/A
- P/E Ratio
- IMAB N/A
- LSBK $12.45
- Revenue Growth
- IMAB N/A
- LSBK 1.75
- 52 Week Low
- IMAB $0.60
- LSBK $11.50
- 52 Week High
- IMAB $5.90
- LSBK $13.48
- Technical
- Relative Strength Index (RSI)
- IMAB 45.33
- LSBK 56.62
- Support Level
- IMAB $3.20
- LSBK $12.96
- Resistance Level
- IMAB $4.64
- LSBK $13.31
- Average True Range (ATR)
- IMAB 0.41
- LSBK 0.19
- MACD
- IMAB -0.17
- LSBK -0.06
- Stochastic Oscillator
- IMAB 29.88
- LSBK 31.75
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.